Nel ASA's Submarine Order Book Is Confirmed — Everything Else Still Isn't

Nel ASA holds about USD 20 million in confirmed Collins Aerospace submarine orders, but SB1 Markets cut its target to NOK 0.30 on profit doubts.

Nel ASA has booked real business. What it has not yet booked is a convincing answer to the question of when, or whether, that business turns into profit.

That gap sits at the heart of the current investment case. Collins Aerospace has placed confirmed orders for PEM electrolyser stacks that generate oxygen for life-support systems aboard US Navy submarines, a concrete application with a named buyer. Yet those contracts do not resolve the broader doubts raised by SB1 Markets, which cut its price target on the Norwegian hydrogen group from NOK 0.50 to NOK 0.30 on 29 September and kept its sell recommendation in place.

Two different kinds of information

The distinction matters because orders and earnings are not interchangeable. SB1 Markets framed its downgrade around an oversupplied electrolyser market and a path to profitability that it cannot clearly identify. The broker put Nel's market share at 5% and flagged a possible need for fresh capital in 2028 — an analyst projection, not a financing plan announced by the company. No causal link between that assessment and any particular share price move can be drawn from it either.

The submarine contracts, by contrast, are documented. Nel Hydrogen US, a subsidiary of Nel ASA, received an initial order worth roughly USD 12 million, according to company statements. Additional naval orders announced about a week later carried a value of approximately USD 7 million and cover programmes in the United States, the United Kingdom and France. Including smaller earlier bookings, Nel puts the total submarine-related intake from Collins Aerospace at around USD 20 million.

Deliveries are scheduled for 2027 and 2028

That headline figure describes orders within a defined programme — it is not a proxy for group revenue, nor a statement about profit. For the additional contracts, deliveries are planned for 2027 and 2028, which ties the order value to a multi-year horizon. A backlog entry alone says nothing about an immediate contribution to the top line.

The scale of the order book is therefore best read alongside its timing. Confirmed demand exists for a clearly bounded use case: equipment for submarines, not a loosely worded ambition to build out hydrogen capacity. Investors who treat the USD 20 million as already-earned business success would be overstating the positive news in much the same way that treating SB1 Markets' capital-need scenario as a certainty would overstate the risk.

October 15 is the next checkpoint

Nel has scheduled its third-quarter 2026 report for 15 October, with publication at 07:00 CET. A virtual results presentation and Q&A session follows at 08:00 CET.

That date gives shareholders the next opportunity to set actual figures and management commentary against the broker's assessment. The useful exercise is to keep the two categories apart: signed orders for future delivery on one side, and the open economic questions — profitability in a crowded market, and the possibility of raising capital later — on the other.